ARTELO BIOSCIENCES, INC. Repayments of Related Party Debt
ARTELO BIOSCIENCES, INC. (ARTL) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2023-03-31
- ARTELO BIOSCIENCES, INC. repayments of related party debt for the quarter ending 2022-12-31 was $0.00.
- ARTELO BIOSCIENCES, INC. repayments of related party debt for the quarter ending 2018-05-31 was $759.00.
- ARTELO BIOSCIENCES, INC. repayments of related party debt for the quarter ending 2018-02-28 was $7.34K.
- ARTELO BIOSCIENCES, INC. repayments of related party debt for the quarter ending 2017-11-30 was $8.51K.
- ARTELO BIOSCIENCES, INC. repayments of related party debt for fiscal 2022 was $0.00.
- ARTELO BIOSCIENCES, INC. repayments of related party debt for fiscal 2021 was $8.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 4 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | ||||
| 2021-12-31 | $1.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-08 | ||||
| 2021-08-31 | $8.00K 10-K · filed 2023-03-31 | ||||
| 2018-05-31 | $759.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-07-13 | $8.10K derived: sum of 2 quarters · filed 2018-07-13 | $16.60K 10-Q · filed 2018-07-13 | ||
| 2018-02-28 | $7.34K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-05-14 | $15.84K 10-Q/A · filed 2018-05-14 | |||
| 2017-11-30 | $8.51K 10-Q/A · filed 2018-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |